purpos
investig
possibl
interrel
antibodi
liter
seven
virus
measl
rubella
herp
simplex
mump
varicellazost
coronaviru
cytomegaloviru
hlaclass
ii
antigen
immunoglobulin
gm
allotyp
multipl
sclerosi
ms
studi
ms
patient
control
similar
age
sex
distribut
ms
patient
found
classic
increas
frequenc
hladqwl
also
excess
gm
mump
antibodi
level
higher
ms
patient
control
elev
signific
measl
antibodi
analysi
suggest
associ
abbrevi
gm
heavi
chain
immunoglobin
g
inserm
villejuif
aa
cb
inserm
caus
multipl
sclerosi
ms
complex
mani
fact
observ
repeatedli
two
last
decad
still
remain
unexplain
elev
antibodi
titer
al
e
found
serum
cerebropinai
fluid
patient
ms
measl
less
frequent
virus
includ
herp
simplex
varicellazost
rubella
vaccinia
influenza
epsteinbarr
virus
find
interpret
variou
way
elev
antibodi
titer
may
either
consequ
diseas
relat
role
variou
common
virus
pathogenesi
ms
anoth
explan
increas
level
viral
hladqwl
antibodi
liter
variou
virus
exist
control
absent
ms
patient
particular
found
mump
antibodi
liter
higher
dqwlposit
dqwlneg
control
signific
differ
among
ms
case
accordingli
found
overal
differ
patient
control
due
fact
dqwlposit
patient
higher
tiler
control
dqwlneg
case
similar
titer
control
find
suggest
biolog
molecular
characterist
dqwl
might
differ
ms
patient
human
immunolog
ms
multipl
sclerosi
bodi
ms
patient
may
relat
immunogenet
factor
associ
ms
thu
specif
structur
co
r
plemer
rite
aatig
immun
respons
viral
antigen
lnighi
control
gene
link
hla
allel
associ
ms
hypothesi
support
sever
report
differ
respons
vaccin
poliomyel
diphtheria
typhoid
vaccinia
viru
viral
antigen
rubella
measl
influenz
epsteinbarr
virus
relat
hla
phenotyp
especi
hladr
antigen
antibodi
level
immun
variou
infecti
agent
depend
also
gene
code
immunoglobulin
g
heavi
chain
gm
associ
gm
allotyp
suscept
ms
report
purpos
studi
investig
possibl
interrel
viral
antibodi
titr
hlaclass
ii
antigen
immunoglobulin
gm
allotyp
ms
patient
control
human
immunolog
present
investig
part
populationbas
casecontrol
studi
ms
conduct
hantespyrnt
dtpartement
jurisdict
southwest
franc
ascertain
ms
case
describ
detail
elsewher
patient
definit
probabl
ms
accord
criteria
poser
et
al
includ
control
group
consist
healthi
individu
similar
age
sex
patient
live
area
select
comparison
geograph
origin
patient
control
document
birthplac
parent
present
investig
restrict
major
histocompat
complex
class
ii
antigen
hladr
hladq
type
perform
twocolor
fluoresc
method
use
anti
hiadr
hladq
alloantisera
monoclon
antibodi
either
local
obtain
exchang
follow
eighth
ninth
histocompat
workshop
sampl
also
test
gm
allotyp
lggl
gm
allotyp
perform
classic
hemagglutin
inhibit
method
opalin
plate
room
temperatur
reagent
use
determin
human
origin
except
allotyp
rabbit
antisera
allotyp
design
rubella
measl
cytomegalovirur
herp
simplex
type
viru
varicella
mump
antibodi
determin
use
elisa
techniqu
enzygnost
behr
titer
defin
compar
optic
densiti
sampl
serial
dilut
known
refer
serum
logdogit
regress
curv
refer
serum
establish
comput
coronaviru
antigen
prepar
laboratori
bovin
enter
coronaviru
becv
stain
cultiv
hrt
human
rectal
adenocarcinoma
kindli
suppli
j
laport
inra
grignon
franc
hrt
cell
grown
rpmi
medium
supplement
fetal
bovin
serum
uml
penicillin
mgml
streptomycin
twodayold
confluent
monolay
inocul
becv
dilut
rpmi
supplement
fetal
bovin
serum
antibiot
inoculum
allow
adsorb
hr
manual
rock
everi
rain
medium
remov
fresh
medium
ad
incub
period
day
cell
cukur
frozen
thaw
suspens
homogen
centrifug
g
rain
superuat
centrifug
g
hr
ultra
centrifug
beckman
rotor
supemat
remov
pellet
homogen
buffer
ph
nahco
centfifug
rain
g
superna
titrat
checkboard
techniqu
use
human
serum
high
titer
coronaviru
antibodi
previous
describ
techniqu
elisa
titrat
use
determin
coronaviru
antibodi
alter
compar
transform
log
reciproc
dilut
geometr
titer
arbitrarili
small
number
assign
trace
undetect
titer
typlng
serolog
measur
perform
blindli
statist
antigen
frequenc
compar
x
test
geometr
titer
twotail
ttest
varianc
analysi
perform
relationship
genet
marker
frequenc
viral
antibodi
titer
patient
popul
studi
ms
patent
femal
male
mean
age
time
studi
yr
patient
retapsingremitr
form
ms
patient
primari
secondari
chronic
progress
cours
diseas
control
n
similar
mean
age
yr
sex
ratio
ms
patient
fortyeight
patient
control
origin
southwest
franc
spain
technic
reason
data
miss
neither
size
ms
patient
group
control
group
ever
lower
antibodi
titer
ms
patient
control
mump
antibodi
titer
significantli
higher
ms
case
control
mean
geometr
titet
respect
p
shown
tabl
patient
control
compar
andbodi
titer
six
virus
antibodi
titer
measl
slightli
higher
ms
patient
control
differ
statist
signific
drlocu
antigen
present
ms
patient
control
p
frequenc
hladqwl
also
higher
patient
control
vs
p
differ
found
oftb
hladr
hladq
antigen
detail
result
gm
allotyp
frequenc
patient
control
report
signific
excess
patient
phenotyp
gm
relationship
viral
antibodi
titer
hladqwl
gm
ms
patient
control
relationship
viral
antibodi
titer
genet
marker
associ
ms
analyz
separ
ms
patient
control
first
result
analysi
antibodi
level
control
correl
presenc
dqwl
tabl
correl
either
posit
negativeaccord
viru
thu
antibodi
titer
measl
rubella
coronaviru
significantli
higher
dqwlposit
dqwlneg
control
antibodi
titer
cytomegaloviru
significantli
elev
dqwlneg
control
gener
pattern
associ
dqwl
viral
antibodi
titer
observ
ms
patient
interestingli
mump
antibodi
titer
differ
significantli
accord
whether
ms
patient
dqwlposit
dqwlneg
two
marker
gm
tabl
appear
relat
viral
antibodi
titer
neither
control
ms
patient
found
new
signific
result
might
interpret
chanc
result
thu
control
higher
level
antibodi
coronaviru
control
phenotyp
gm
significantli
associ
higher
titer
cytomegaloviru
control
lower
titer
varicellazost
ms
patient
whole
viral
antibodi
level
similar
gm
phenotyp
second
step
part
analysi
compar
antibodi
titer
ms
patient
control
within
six
subgroup
ident
hladqwl
gm
phenotyp
overal
immunogenet
adjust
veal
signific
differ
ms
patient
control
except
mump
point
fig
repres
differ
mean
mump
antibodi
titer
ms
patient
control
six
subgroup
point
zero
line
titer
higher
patient
control
multipl
sclerosi
patient
posit
dqwl
significantli
higher
level
antibodi
mump
dqwlposit
control
mump
antibodi
titer
similar
dqwlneg
patient
dqwlneg
control
also
ms
patient
higher
titer
control
differ
statist
signific
two
subgroup
defin
accord
gm
phenotyp
antibodi
titer
higher
ms
patient
control
fig
besid
classic
associ
ms
hladqwl
found
increas
frequenc
gm
ms
patient
live
hautespyrtn
comparison
control
live
area
antibodi
titer
seven
virus
measur
antimump
antibodi
level
significantli
higher
ms
patient
control
signific
differ
found
measl
howev
ms
patient
slightli
higher
titer
control
associ
antibodi
titer
immunogenet
marker
analyz
first
import
observ
viral
antibodi
titer
control
individu
vari
significantli
depend
presenc
absenc
dqwl
presenc
dqwl
antigen
associ
elev
antibodi
titer
measl
rubella
coronaviru
low
antibodi
titer
cytomegaloviru
differ
basic
biolog
molecular
properti
virus
may
explain
correl
hla
antigen
viral
antibodi
titer
either
posit
neg
convers
well
known
peptid
antigen
associ
hlaclass
ii
molecul
order
present
cell
affin
viru
peptid
could
vari
differ
hiaclass
ii
molecul
give
rise
variabl
immun
respons
shown
influenza
matrix
peptid
correl
variou
hla
antigen
especi
class
ii
antigen
antibodi
titer
report
normal
individu
kato
et
al
suggest
gene
control
tow
respons
rubella
might
locat
sixth
chromosom
near
hladr
locu
cohen
et
al
observ
individu
significantli
higher
antibodi
titer
epsteinbarr
viru
capsid
nuclear
antigen
without
studi
done
hladqwl
identifi
multipl
sclerosi
patient
differ
control
ms
group
viral
antibodi
titer
relat
dqwl
remark
except
mump
therefor
studi
suggest
associ
hladqwl
antibodi
titer
variou
virus
exist
normal
individu
absent
ms
patient
previou
studi
relationship
hla
antigen
vral
antibodi
titer
ms
patient
focus
measl
viru
follow
studi
jersild
et
al
show
associ
high
measl
antibodi
titer
antigen
sever
neg
report
publish
relationship
note
hla
type
measl
antibodi
titer
within
famili
sever
affect
individu
poskans
et
al
correl
hla
phenotyp
antibodi
direct
eight
virus
patient
ms
found
associ
studi
done
hladr
antigen
yet
defin
knowledg
publish
result
interrelationship
class
ii
antigen
viral
antibodi
titer
ms
may
note
interrelationship
hlaclass
ii
antigen
viral
antibodi
titer
found
insulindepend
diabet
alcohol
cirrhosi
clear
explan
find
easi
may
suggest
ms
patient
immunolog
dysfunct
interfer
normal
control
immun
respons
gene
belong
link
hla
region
attract
hypothesi
biolog
molecular
characterist
dqwl
might
differ
ms
patient
gene
nonlink
dq
influenc
function
control
molecul
involv
cellular
adhes
lymphocyt
antigenpres
cell
could
also
play
role
modif
viral
immun
respons
ms
major
find
studi
observ
compar
mump
antibodi
titer
ms
case
controi
found
differ
ms
case
control
could
attribut
differ
dqwlposit
case
control
contrast
mump
antibodi
titer
similar
dqwlneg
ms
patient
control
studi
support
possibl
role
mump
viru
ms
local
synthesi
central
nervou
system
oligoclon
antibodi
mump
virus
neurotrop
properti
observ
sever
studi
includ
multipl
comparison
viral
antibodi
titer
ms
patient
co
ol
done
hxgher
titer
mump
antibodi
ms
case
control
report
signific
associ
may
occur
chanc
must
interpret
caution
howev
fact
elev
antibodi
titer
mump
ms
patient
depend
presenc
absenc
dqwl
hla
antigen
associ
suscept
ms
popul
give
consist
find
rais
question
whether
differ
mump
antibodi
titer
ms
patient
control
might
due
particular
dqwl
characterist
present
patient
particularli
characterist
might
play
role
suscept
ms
